INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 46h ago
House PTR6h ago
SEC 13F6h ago
Robinhood Chain6h ago

Results

77,421 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$107K
14.7K sh
Apr 9, 2026
Page 1156 of 1936
← PrevNext →
Apr 13, 2026
traded Apr 9, 2026
+4d
SEC Form 4

Evidence

0
NS
Nagendran SukumarDirector, President and Head of R&D
TSHATaysha Gene Therapies, Inc.
Option exercise · 10b5-1 plan
M$33K
19.0K sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

0
PO
Pomel OlivierDirector, Chief Executive Officer
DDOGDatadog, Inc.
Option exercise · 10b5-1 plan
M—
35.7K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

0
PO
Pomel OlivierDirector, Chief Executive Officer
DDOGDatadog, Inc.
Option exercise · 10b5-1 plan
M$35K
38.1K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

0
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
2,170 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

0
PE
Pelish Henry E.Chief Scientific Officer
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M$86K
3,093 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

0
PC
Perducat CyrilSVP, Chief Technology Officer
ROKROCKWELL AUTOMATION, INC
Option exercise · 10b5-1 plan
M—
581 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

0
PO
Pomel OlivierDirector, Chief Executive Officer
DDOGDatadog, Inc.
Derivative conversion · 10b5-1 plan
C—
42.4K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
6,613 sh
Apr 13, 2026Apr 13, 2026
traded Apr 13, 2026
+0dSEC Form 4

Evidence

0
TY
Tan Anthony Ping YeowDirector, Chief Executive Officer
GRABGrab Holdings Ltd
Derivative conversion · 10b5-1 plan
C—
800.0K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
8,109 sh
Apr 13, 2026Apr 13, 2026
traded Apr 13, 2026
+0dSEC Form 4

Evidence

0
NS
Nagendran SukumarDirector, President and Head of R&D
TSHATaysha Gene Therapies, Inc.
Option exercise · 10b5-1 plan
M—
19.0K sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
14.7K sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

0
CM
Chang MichelleChief Financial Officer
ZMZoom Communications, Inc.
Option exercise · 10b5-1 plan
M—
0 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

0
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$35K
2,170 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

0
HR
Howard Justyn RussellDirector, Executive Chair, 10% Owner
SPTSprout Social, Inc.
Derivative conversion · 10b5-1 plan
C—
40.0K sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$56K
6,613 sh
Apr 13, 2026Apr 13, 2026
traded Apr 13, 2026
+0dSEC Form 4

Evidence

56
GG
George GregoryDirector, 10% Owner
MESOMESOBLAST LTD
Open-market purchase
BUY$5.68M
4.00M sh
Apr 4, 2026Apr 10, 2026
traded Apr 4, 2026
+6dSEC Form 4

Evidence

51
VR
Velaga S. RamPresident, ISG
AVGOBroadcom Inc.
Open-market sale
SELL$6.08M
17.3K sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

51
PJ
Page JustineDirector
AVGOBroadcom Inc.
Open-market sale
SELL$712K
2,018 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

50
KB
Kawwas Charlie BPresident, SSG
AVGOBroadcom Inc.
Open-market sale
SELL$3.45M
10.0K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

47
DW
Da Cunha Gustavo WerneckCEO and Board Member
GGBGERDAU S.A.
Open-market sale
SELL$201K
50.0K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

47
VR
Velaga S. RamPresident, ISG
AVGOBroadcom Inc.
Open-market sale
SELL$4.56M
13.0K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

45
CC
Collier CharlesPresident, Roku Media
ROKUROKU, INC
Open-market sale · 10b5-1 plan
SELL$21.61M
205.8K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

43
OL
O'Shaughnessy LauraDirector
AYIACUITY INC. (DE)
Open-market purchase
BUY$283K
1,000 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

43
WY
Wang Chia YuanSenior management
GGBGERDAU S.A.
Open-market sale
SELL$136K
34.0K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

43
DW
Da Cunha Gustavo WerneckCEO and Board Member
GGBGERDAU S.A.
Open-market sale
SELL$208K
50.0K sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

42
IF
Isaksen Bjorn Andreas FrengDirector
HSHPHimalaya Shipping Ltd.
Open-market sale
SELL$4.02M
300.0K sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

39
GG
George GregoryDirector, 10% Owner
MESOMESOBLAST LTD
Open-market purchase
BUY$3.44M
2.32M sh
Apr 10, 2026Apr 10, 2026
traded Apr 10, 2026
+0dSEC Form 4

Evidence

38
GG
George GregoryDirector, 10% Owner
MESOMESOBLAST LTD
Open-market purchase
BUY$1.27M
886.9K sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

36
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$3.45M
38.7K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

36
JS
Jain SachinChief Operating Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$364K
3,953 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

34
GG
George GregoryDirector, 10% Owner
MESOMESOBLAST LTD
Open-market purchase
BUY$7.20M
500.0K sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

34
GG
George GregoryDirector, 10% Owner
MESOMESOBLAST LTD
Open-market purchase
BUY$7.20M
500.0K sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

34
CB
Canton Barry10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Open-market sale
SELL$91K
13.2K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

34
SP
Shetty Reshma P.Director, See remarks, 10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Open-market sale
SELL$91K
13.2K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

33
GC
Goldberg ChenEVP, Product & Engineering
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$898K
9,757 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

32
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1.16M
13.1K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

32
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$3.45M
38.7K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

32
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1.04M
11.8K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence